Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Keratosis, Actinic 18 Brain Neoplasms 18 Glioblastoma 16 Glioma 15 Carcinoma, Basal Cell 7 Astrocytoma 5 Gliosarcoma 4 Skin Neoplasms 3 Precancerous Conditions 3 Oligodendroglioma 3 Mouth Neoplasms 3 Carcinoma, Squamous Cell 3 Squamous Intraepithelial Lesions 2 Skull Base Neoplasms 2 Sarcoma 2 Pituitary Neoplasms 2 Neoplasms 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Head and Neck Neoplasms 2 Central Nervous System Neoplasms 2 Basal Cell Nevus Syndrome 2 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sezary Syndrome 1 Oropharyngeal Neoplasms 1 Nonmelanoma Skin Cancers 1 Non-Melanoma Skin Cancer (NMSC) 1 Neurofibromatosis 1 1 Neurofibromatoses 1

Interventions

Gemcitabine 87 Cisplatin 66 Cystectomy 38 pembrolizumab 34 Docetaxel 25 Nivolumab 24 durvalumab 21 Paclitaxel 19 Magnetic Resonance Spectroscopy 18 Radiotherapy 17 Mitomycin 17 Carboplatin 16 atezolizumab 15 Doxorubicin 14 Cystoscopy 14 BCG Vaccine 13 Surveys and Questionnaires 12 Standard of Care 12 avelumab 11 Sunitinib 10 tremelimumab 9 Transurethral Resection of Bladder 9 Ipilimumab 9 Filgrastim 9 Blood Specimen Collection 9 Specimen Handling 8 Neoadjuvant Therapy 8 Methotrexate 8 Methods 8 Early Intervention, Educational 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Urinary Bladder Neoplasms × Aminolevulinic Acid × Clear all

NCT02101931 2016-03-31

ALA

Princess Al-Johara Al-Ibrahim Cancer Research Center

Phase 3 Completed

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡